1. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
   Kurt Sartorius et al, 2022, Frontiers in Oncology CrossRef
2. Maxizyme-mediated specific inhibition on mutant-type p53in vitro
   Xin-Juan Kong, 2003, World Journal of Gastroenterology CrossRef
3. VEGF165antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma
   Zhong-Ping Gu, 2002, World Journal of Gastroenterology CrossRef